# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA2090420 | B | Inhibition of Bcl2-BAK interaction after 1 hr by surface plasmon resonance assay | 24 | ALA2086363 | protein format | Scientific Literature | ||
2. | ALA2090421 | B | Inhibition of Bcl-XL-BAK interaction | 3 | ALA2086363 | protein format | Scientific Literature | ||
3. | ALA2090422 | B | Selectivity ratio of EC50 for Bcl-XL-BAK interaction to EC50 for Bcl2-BAK interaction | 1 | ALA2086363 | assay format | Scientific Literature | ||
4. | ALA2090423 | B | Inhibition of Mcl1-BAK interaction | 14 | ALA2086363 | protein complex format | Scientific Literature | ||
5. | ALA2090424 | A | Clearance in Sprague-Dawley rat at 1 mg/kg, iv and 10 mg/kg, po | Rattus norvegicus | 2 | ALA2086363 | organism-based format | Scientific Literature | |
6. | ALA2090425 | A | Volume of distribution at steady state in Sprague-Dawley rat at 1 mg/kg, iv and 10 mg/kg, po | Rattus norvegicus | 2 | ALA2086363 | organism-based format | Scientific Literature | |
7. | ALA2090426 | A | Half life in Sprague-Dawley rat at 1 mg/kg, iv and 10 mg/kg, po | Rattus norvegicus | 2 | ALA2086363 | organism-based format | Scientific Literature | |
8. | ALA2090427 | A | Oral bioavailability in Sprague-Dawley rat at 10 mg/kg | Rattus norvegicus | 2 | ALA2086363 | organism-based format | Scientific Literature |